Consegna Pharma
Consegna Pharma Inc. is a specialty pharmaceutical company dedicated to creating best-in-class long-acting medications. Their mission focuses on developing innovative solutions such as long-acting Naloxone to combat opioid overdoses, aiming to improve overdose reversal treatments and prevent secondary overdoses. The company is located at 2403 Sidney St., Suite 255, Pittsburgh, PA 15203.
Industries
Nr. of Employees
small (1-50)
Consegna Pharma
Pittsburgh, Pennsylvania, United States, North America
Products
Long-acting naloxone formulation (12–24 hour release)
A sustained-release naloxone formulation designed to provide 12–24 hours of drug exposure to reduce the need for repeated dosing and help prevent renarcotization after opioid overdose.
CP216
An investigational opioid overdose reversal product that releases an immediate dose of free naloxone followed by a sustained, long-acting release of naloxone over 24 hours to prevent renarcotization from synthetic opioids.
ADSR
Computational Drug Delivery artificial intelligence (AI) based software that calculates formulation specifications using active ingredient, excipient, desired release performance, and end environment data.
Computational Drug Delivery
A proprietary technology platform used to design long-acting injectable medications faster and with reduced regulatory and technical risk.
Long-acting naloxone formulation (12–24 hour release)
A sustained-release naloxone formulation designed to provide 12–24 hours of drug exposure to reduce the need for repeated dosing and help prevent renarcotization after opioid overdose.
CP216
An investigational opioid overdose reversal product that releases an immediate dose of free naloxone followed by a sustained, long-acting release of naloxone over 24 hours to prevent renarcotization from synthetic opioids.
ADSR
Computational Drug Delivery artificial intelligence (AI) based software that calculates formulation specifications using active ingredient, excipient, desired release performance, and end environment data.
Computational Drug Delivery
A proprietary technology platform used to design long-acting injectable medications faster and with reduced regulatory and technical risk.
Expertise Areas
- Long-acting drug delivery
- Formulation development
- Opioid overdose therapeutics
- Sustained-release product design
Key Technologies
- Sustained-release / extended-release formulations
- Long-acting drug delivery systems
- Controlled-release formulation techniques